Testing Data
(Detection of SMAD7 with MBS602141. Lysates from human H9, mouse PT18, and rat Rat2 cells were resolved by SDS-PAGE, transferred to a membrane and immunoblotted with 1ug/ml MBS602141. A one minute exposure to film is shown.)
Mouse Smad7 Monoclonal Antibody | anti-SMAD7 antibody
Smad7 (Small Mothers against Decapentaplegic Deleted in Pancreatic Carcinoma)
Purified by Protein G affinity chromatography.
Purified by Protein G affinity chromatography.
Dilution: Western Blot: 1ug/ml
Immunohistochemistry: 8-25ug/ml with appropriate secondary reagents to detect SMAD7 in paraffin-embedded human liver cancer tissue sections.
Testing Data
(Detection of SMAD7 with MBS602141. Lysates from human H9, mouse PT18, and rat Rat2 cells were resolved by SDS-PAGE, transferred to a membrane and immunoblotted with 1ug/ml MBS602141. A one minute exposure to film is shown.)
Testing Data
(Detection of SMAD7 with MBS602141. Lysates from human H9, mouse PT18, and rat Rat2 cells were resolved by SDS-PAGE, transferred to a membrane and immunoblotted with 1ug/ml MBS602141. A one minute exposure to film is shown.)
Immunohistochemistry (IHC)
(Smad7 was detected in immersion fixed paraffin embedded sections of human liver cancer tissue using 25ug/mL MBS602141 overnight at 4 °C. Tissue was stained with the Anti Mouse HRPDAB Cell & Tissue Staining Kit (brown) and counterstained with hematoxylin (blue).)
Immunohistochemistry (IHC)
(Smad7 was detected in immersion fixed paraffin embedded sections of human liver cancer tissue using 25ug/mL MBS602141 overnight at 4 °C. Tissue was stained with the Anti Mouse HRPDAB Cell & Tissue Staining Kit (brown) and counterstained with hematoxylin (blue).)
NCBI and Uniprot Product Information
NCBI Description
The protein encoded by this gene is a nuclear protein that binds the E3 ubiquitin ligase SMURF2. Upon binding, this complex translocates to the cytoplasm, where it interacts with TGF-beta receptor type-1 (TGFBR1), leading to the degradation of both the encoded protein and TGFBR1. Expression of this gene is induced by TGFBR1. Variations in this gene are a cause of susceptibility to colorectal cancer type 3 (CRCS3). Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq]
Uniprot Description
SMAD7: Antagonist of signaling by TGF-beta (transforming growth factor) type 1 receptor superfamily members; has been shown to inhibit TGF-beta (Transforming growth factor) and activin signaling by associating with their receptors thus preventing SMAD2 access. Functions as an adapter to recruit SMURF2 to the TGF-beta receptor complex. Also acts by recruiting the PPP1R15A- PP1 complex to TGFBR1, which promotes its dephosphorylation. Positively regulates PDPK1 kinase activity by stimulating its dissociation from the 14-3-3 protein YWHAQ which acts as a negative regulator. Genetic variations in SMAD7 influence susceptibility to colorectal cancer type 3 (CRCS3). Colorectal cancer consists of tumors or cancer of either the colon or rectum or both. Cancers of the large intestine are the second most common form of cancer found in males and females. Symptoms include rectal bleeding, occult blood in stools, bowel obstruction and weight loss. Treatment is based largely on the extent of cancer penetration into the intestinal wall. Surgical cures are possible if the malignancy is confined to the intestine. Risk can be reduced when following a diet which is low in fat and high in fiber. Belongs to the dwarfin/SMAD family.
Protein type: Transcription factor; DNA-binding
Chromosomal Location of Human Ortholog: 18q21.1
Cellular Component: nucleoplasm; transcription factor complex; protein complex; cell-cell adherens junction; cytoplasm; plasma membrane; catenin complex; cytosol; nucleus
Molecular Function: collagen binding; protein binding; metal ion binding; ubiquitin protein ligase binding; beta-catenin binding; activin binding; transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity; transcription factor activity
Biological Process: transcription initiation from RNA polymerase II promoter; protein stabilization; transcription, DNA-dependent; negative regulation of transcription factor activity; negative regulation of peptidyl-serine phosphorylation; negative regulation of transcription from RNA polymerase II promoter; regulation of activin receptor signaling pathway; negative regulation of BMP signaling pathway; BMP signaling pathway; regulation of transforming growth factor beta receptor signaling pathway; ureteric bud development; positive regulation of protein ubiquitination; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; transforming growth factor beta receptor signaling pathway; positive regulation of cell-cell adhesion; negative regulation of ubiquitin-protein ligase activity; artery morphogenesis; ventricular cardiac muscle morphogenesis; positive regulation of transcription from RNA polymerase II promoter; negative regulation of protein ubiquitination; gene expression; negative regulation of transforming growth factor beta receptor signaling pathway; negative regulation of cell migration
Disease: Colorectal Cancer, Susceptibility To, 3
Research Articles on SMAD7
Similar Products
Product Notes
The SMAD7 smad7 (Catalog #AAA602141) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. The Smad7 (Small Mothers against Decapentaplegic Deleted in Pancreatic Carcinoma) reacts with Human, Mouse, Rat and may cross-react with other species as described in the data sheet. AAA Biotech's Smad7 can be used in a range of immunoassay formats including, but not limited to, Western Blot (WB), Immunohistochemistry (IHC). Suitable for use in Western Blot and Immunohistochemistry. Dilution: Western Blot: 1ug/ml Immunohistochemistry: 8-25ug/ml with appropriate secondary reagents to detect SMAD7 in paraffin-embedded human liver cancer tissue sections. Researchers should empirically determine the suitability of the SMAD7 smad7 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process. It is sometimes possible for the material contained within the vial of "Smad7, Monoclonal Antibody" to become dispersed throughout the inside of the vial, particularly around the seal of said vial, during shipment and storage. We always suggest centrifuging these vials to consolidate all of the liquid away from the lid and to the bottom of the vial prior to opening. Please be advised that certain products may require dry ice for shipping and that, if this is the case, an additional dry ice fee may also be required.Precautions
All products in the AAA Biotech catalog are strictly for research-use only, and are absolutely not suitable for use in any sort of medical, therapeutic, prophylactic, in-vivo, or diagnostic capacity. By purchasing a product from AAA Biotech, you are explicitly certifying that said products will be properly tested and used in line with industry standard. AAA Biotech and its authorized distribution partners reserve the right to refuse to fulfill any order if we have any indication that a purchaser may be intending to use a product outside of our accepted criteria.Disclaimer
Though we do strive to guarantee the information represented in this datasheet, AAA Biotech cannot be held responsible for any oversights or imprecisions. AAA Biotech reserves the right to adjust any aspect of this datasheet at any time and without notice. It is the responsibility of the customer to inform AAA Biotech of any product performance issues observed or experienced within 30 days of receipt of said product. To see additional details on this or any of our other policies, please see our Terms & Conditions page.Item has been added to Shopping Cart
If you are ready to order, navigate to Shopping Cart and get ready to checkout.
